MAPT and neuroblastoma: We initially tested the system in dividing neuroblastoma IMR cells with constructs encoding the inducible expression of 3R and 4R wild-type (or P301L mutant) Tau fused at the C-terminus to an enhanced green fluorescent protein (EGFP).